Search Within

Amin Taher Yaqubie

Formats
  1. Journal Article (13)
  2. Meeting Abstract (13)
Groups
  1. Department of Medicine (26)
  2. Solid Tumor Oncology Division (26)
  3. Gastrointestinal Oncology Service (25)
  4. Center for Pancreatic Cancer Research (15)
  5. Epidemiology and Biostatistics (14)
  6. GSK Faculty (12)

More Groups

People
  1. Ghassan Abou-Alfa (22)
  2. James Harding (15)
  3. Eileen O'Reilly (12)
  4. Imane El Dika (12)
  5. Danny Khalil (8)
  6. David Solit (8)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (5)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Oncology (3)
  3. Cancer Medicine (2)
  4. JCO Global Oncology (2)
  5. JCO Precision Oncology (2)
  6. The Oncologist (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (14)
  2. Oxford University Press (5)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)
  5. Karger (1)
  6. Springer (1)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy
    Meeting Abstract

    Keane, F.; Cowzer, D.; Khalil, D.; Shia, J.; Do, R.; Folorunso, S.; El Dika, I.; Yaqubie, A.; Kim, T.; O'Reilly, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Fertility post immune checkpoint blockade
    Meeting Abstract

    Ogle, M.; Harrold, E.; O'Brien, E.; Weiss, J. A.; Yaqubie, A.; Sinopoli, J. C.; Postow, M. A.; Cercek, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data
    Journal Article

    Zack, T.; Losert, K. P.; Maisel, S. M.; Wild, J.; Yaqubie, A.; Herman, M.; Knox, J. J.; Mayer, R. J.; Venook, A. P.; Butte, A.; more...
    npj Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer
    Meeting Abstract

    Mondaca, S.; Schultz, N.; Roa, J. C.; Walch, H. S.; Sepulveda, S.; Harding, J. J.; Yaqubie, A.; Garcia, P.; Aguayo, G.; Nervi, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Effect of FGFR2 alterations on overall and progression-free survival in patients receiving systemic therapy for intrahepatic cholangiocarcinoma
    Journal Article

    Abou-Alfa, G. K.; Bibeau, K.; Schultz, N.; Yaqubie, A.; Millang, B.; Ren, H.; FeĢliz, L.
    Targeted Oncology (2022)

    Fulltext@MSK | Save
  • Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States
    Journal Article

    Zou, C.; El Dika, I.; Vercauteren, K. O. A.; Capanu, M.; Chou, J.; Shia, J.; Pilet, J.; Quirk, C.; Lalazar, G.; Andrus, L.; more...
    Cancer Medicine (2022)

    Fulltext@MSK | Save
  • Computational extraction and analysis of de-identified medical records to characterize hyperammonemia in patients with fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Zack, T.; Maisel, S.; O'Neill, A. F.; La Quaglia, M. P.; Herman, M.; Knox, J. J.; Yaqubie, A.; Venook, A. P.; Mayer, R. J.; Gordan, J. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma
    Journal Article

    Harding, J. J.; Do, R. K.; Yaqubie, A.; Cleverly, A.; Zhao, Y.; Gueorguieva, I.; Lahn, M.; Benhadji, K. A.; Kelley, R. K.; Abou-Alfa, G. K.
    Cancer Medicine (2021)

    Fulltext@MSK | Save